Yang Song Email
Vice President (Global R and D), Head of Immunology and CNS and CEO and CMO, Hygtia Therapeutics @ Fosun Pharma
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Yang Song Location
- Shanghai, CN
Yang Song Work
- Vice President (Global R and D), Head of Immunology and CNS and CEO and CMO, Hygtia Therapeutics @ (September 2024 - Present)
- Global Development China Country Lead and Head of China Portfolio and Asset Program Management (all TAs) @ (October 2020 - September 2024)
- Clinical Development (Global R and D, Immunology TA) @ (August 2019 - September 2020)
- China TA Head and Head of China Compound Team Leaders (Cardiovascular and Metabolism, Immunology TAs) @ (April 2015 - June 2019)
- Discovery Medicine Physician and Early Clinical Development (Global R and D, CNS and Neuroinflammation) @ (January 2014 - March 2015)
- Principle Clinical Research Scientist and Clinical Lead (AP R and D, Cardiovascular) @ (February 2013 - January 2014)
- China TA Lead (CNS, Pain) @ (February 2011 - February 2013)
- Clinical Neurologist @ (August 2010 - February 2011)
- Medical Reviewer (CNS, Cardiovascular, Stroke) @ (August 2007 - February 2011)
- Clinical Neurologist @ (September 2005 - July 2010)
Yang Song Education
- Yale University
MAM (Business/Commerce, General)
2018-2019 - The University of British Columbia
Master of Business Administration - MBA (Business Administration and Management, General)
2016-2018 - Peking Union Medical College
Doctor of Philosophy - PhD (Neurology & Neuroscience)
2005-2010 - Chongqing Medical University
Doctor of Medicine - MD (Clinical Medicine)
1998-2003
Yang Song Skills
- Biomarkers
- Business Development
- Business Strategy
- Cardiovascular Disease
- Cardiovasular and Metabolism
- Cerebrovascular Disease
- Clinical Development
- Clinical Research
- Clinical Trials
- Compound Management
- Drug Development
- Early Stage Clinical Development
- Entrepreneurship
- Immunology
- Matrix Leadership
- Medical Device R&D
- Medical Monitoring
- Neuroimaging
- Neuroimmunology
- Neurointervention
- Neurology
- Neuropathic Pain
- Neurosonology
- Pharmacovigilance
- Pre-clinical Studies
- Product Development
- Psychiatry
- R&D Portfolio Management
- Strategic Planning
- Strategy
- Stroke
- clinical reasearch
Yang Song Summary
- Yang Song, based in Shanghai, CN, is currently a Vice President (Global R and D), Head of Immunology and CNS and CEO and CMO, Hygtia Therapeutics at Fosun Pharma. Yang Song brings experience from previous roles at Johnson & Johnson Innovative Medicine and GSK. Yang Song holds a 2018 - 2019 MAM in Business/Commerce, General @ Yale University. With a robust skill set that includes Biomarkers, Business Development, Business Strategy, Cardiovascular Disease, Cardiovasular and Metabolism and more.
Looking for a different Yang Song?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co